Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Wen Xing Peng"'
Autor:
Bei He, Yun Li, Wen-wen Luo, Xuan Cheng, Huai-rong Xiang, Qi-zhi Zhang, Jie He, Wen-xing Peng
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
ObjectivesTo evaluate the safety of each anti-TNF therapy for patients with rheumatoid arthritis (RA) and then make the best choice in clinical practice.MethodsWe searched PUBMED, EMBASE, and the Cochrane Library. The deadline for retrieval is August
Externí odkaz:
https://doaj.org/article/83c1c4d33eee41b5bb6f8960ec914164
Autor:
Yi Zhang, Xiu-Jin Shi, Wen-Xing Peng, Jia-Lun Han, Bai-Di Lin, Ru Zhang, Yun-Nan Zhang, Jia-Lin Yan, Juan-Juan Wei, Yi-Fan Wang, Su-Wei Chen, Nan Nan, Zhen-Wei Fang, Yong Zeng, Yang Lin
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Background: CYP2C19 loss-of-function (LOF) alleles reduce the effectiveness of clopidogrel in patients undergoing percutaneous coronary intervention for acute coronary syndrome. However, the clinical impact of implementing CYP2C19 gene-guided pharmac
Externí odkaz:
https://doaj.org/article/5df600e0be274a23a26d10d031351c23
Publikováno v:
Urologia Internationalis. 106:869-877
Introduction: The aim of this article was to investigate the relationship between statins and the risk of different stages or grades of prostate cancer. Methods: A comprehensive literature search was performed for articles published until December 18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a270e4e1e21a8fea6f3336c17406b652
https://doi.org/10.1159/000518164
https://doi.org/10.1159/000518164
Publikováno v:
Journal of applied toxicology : JATREFERENCES. 42(7)
As a serious infectious disease, tuberculosis threatens global public health. Isoniazid is the first-line drug not only in active tuberculosis but also in its prevention. Severe hepatotoxicity greatly limits its use. Curcumin, extracted from turmeric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc3bedfdb83d5ec32ab1a8cc0e08fd8f
https://pubmed.ncbi.nlm.nih.gov/35032049
https://pubmed.ncbi.nlm.nih.gov/35032049
Publikováno v:
Journal of medical virologyREFERENCES. 94(5)
Bamlanivimab is routinely used in the treatment of coronavirus disease 2019 (COVID-19) worldwide. We performed a meta-analysis to investigate the efficacy and safety of bamlanivimab treatment in patients with COVID-19. We searched articles from Web o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6931ec0e87614189edaecbaf6d207363
https://pubmed.ncbi.nlm.nih.gov/34936121
https://pubmed.ncbi.nlm.nih.gov/34936121
BackgroundBamlanivimab is routinely used in the treatment of coronavirus disease 2019 (COVID-19) in worldwide. We performed a meta-analysis to investigate the efficacy and safety of bamlanivimab treatment in patients with COVID-19.MethodsWe searched
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be903842ea3c199aa570d1afe94849a8
https://doi.org/10.1101/2021.08.24.21262580
https://doi.org/10.1101/2021.08.24.21262580
Publikováno v:
Journal of applied toxicology : JATREFERENCES. 42(3)
Isoniazid (INH)-induced liver injury is a great challenge for tuberculosis treatment. Existing biomarkers cannot accurately determine the occurrence of this injury in the early stage. Therefore, developing early specific sensitive biomarkers of INH-i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c286637e74a061064fe709edae8f31f
https://pubmed.ncbi.nlm.nih.gov/34494278
https://pubmed.ncbi.nlm.nih.gov/34494278
Publikováno v:
International Immunopharmacology
Background The benefit of IVIG (Intravenous Immunoglobulin) therapy for COVID-19 remains controversial. We performed a meta-analysis to investigate the efficacy of IVIG treatment in patients with COVID-19. Methods We searched articles from Web of Sci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ca37f033dfc8f6fd5a464af853e72cd
https://pubmed.ncbi.nlm.nih.gov/34162133
https://pubmed.ncbi.nlm.nih.gov/34162133
Publikováno v:
Xenobiotica. 47:154-163
Combination of isoniazid (INH) and rifampicin (RFP) causes liver injury frequently among tuberculosis patients. However, mechanisms of the hepatotoxicity are not entirely understood. Protoporphyrin IX (PPIX) accumulation, as an endogenous hepatotoxin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09712130e332e9f13dbea4302ac5a24f
https://doi.org/10.3109/00498254.2016.1160159
https://doi.org/10.3109/00498254.2016.1160159
Publikováno v:
Journal of Applied Toxicology; Mar2022, Vol. 42 Issue 3, p516-528, 13p